Company intelligence / Profile preview

Guangzhou Younan Technology

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangzhou Younan Technology operates as a life science tool provider and CRO/CDMO. While primarily focused on research reagents and chemical synthesis services, the company has engaged in the discovery of lead compounds targeting BRD4 for oncology. Their lead compounds 11h and 11r have demonstrated potent binding to BRD4 and anti-proliferative activity against acute myeloid leukemia cells (MV4-11) in pre-clinical studies, specifically inhibiting oncogenes like c-Myc and CDK6.

Therapeutic areas: HematologyImmunologyCardiovascularEndocrinologyOncology
Modalities: Small moleculeAntisense oligonucleotidePeptides
Industry: Biotech

Partnerships

China Three Gorges University

Beyond the preview

Go deeper on Guangzhou Younan Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Younan Technology.

Explore the full profile